Amneal Pharmaceuticals Inc (AMRX)

03:15 AM

Amneal Pharmaceuticals Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

03:15 AM

08:57 AM

What drives Amneal Pharmaceuticals Inc. stock priceLightning-fast growth - Autocar Professional

08:57 AM

03:43 AM

What analysts say about Amneal Pharmaceuticals Inc. stockSignificant capital appreciation - Autocar Professional

03:43 AM

Jul 22, 2025

Is Amneal Pharmaceuticals Inc. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Amneal Announces Proposed Refinancing of Existing Credit - GlobeNewswire

Jul 22, 2025

Jul 21, 2025

Amneal reports 3% revenue growth in Q2, advances deleveraging - Investing.com India

Jul 21, 2025

Jul 21, 2025

Amneal (AMRX) targets $2.55B debt refinancing via loans & notes | AMRX SEC FilingForm 8-K - Stock Titan

Jul 21, 2025

Jul 21, 2025

Amneal Pharmaceuticals Reports Preliminary Q2 2025 Financial Results Indicating Growth and Deleveraging Efforts - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

Amneal Pharmaceuticals Unveils Massive $2.55 Billion Debt Restructuring PlanWhat's Changing - Stock Titan

Jul 21, 2025

Jul 18, 2025

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada - The Manila Times

Jul 18, 2025

Jul 18, 2025

Thérapeutique Knight annonce le dépôt d’une nouvelle soumission réglementaire pour CREXONT® (carbidopa et lévodopa) au Canada en capsules à libération prolongée - GlobeNewswire Inc.

Jul 18, 2025

Jul 16, 2025

Parkinson's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com

Jul 16, 2025

Jul 13, 2025

Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension - MSN

Jul 13, 2025

Jul 10, 2025

Amneal to Report Second Quarter 2025 Results on August 5, 2025 - GlobeNewswire

Jul 10, 2025

Jul 09, 2025

Amneal Earnings: How to Join Q2 2025 Results Call on August 5 - Stock Titan

Jul 09, 2025

Jul 04, 2025

Riot Platforms selling more Bitfarms (BITF) - The Globe and Mail

Jul 04, 2025

Jul 02, 2025

Analysts Bullish as Amneal Pharmaceuticals, Inc. (AMRX) Director Sells Over 94K Shares - Yahoo Finance

Jul 02, 2025

Jun 30, 2025

Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Jun 30, 2025

Jun 27, 2025

Kashiv’s Xolair Biosimilar Nears US And EU Filings As Phase III Data Reports - insights.citeline.com

Jun 27, 2025

Jun 26, 2025

5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call - FinancialContent

Jun 26, 2025

Jun 25, 2025

Kashiv BioSciences Announces Positive Topline Results from Confirmatory Efficacy Study of ADL-018, Biosimilar Candidate to XOLAIR® (omalizumab) - Business Wire

Jun 25, 2025

Jun 24, 2025

Amneal Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMRX - Nasdaq

Jun 24, 2025

Jun 19, 2025

Investing in Amneal Pharmaceuticals (NASDAQ:AMRX) three years ago would have delivered you a 157% gain - simplywall.st

Jun 19, 2025

Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmac - GuruFocus

Jun 18, 2025

Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

Jun 18, 2025

Jun 17, 2025

Parkinson’s Disease Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharma, Pharma Two B, Jazz Pharma - Barchart.com

Jun 17, 2025

Jun 17, 2025

Parkinson's Disease Market to Show Remarkable Growth Trends - openPR.com

Jun 17, 2025

Jun 13, 2025

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - Yahoo Finance

Jun 13, 2025

Jun 13, 2025

Epinephrine Autoinjector Market Size, Share, and Competitive - openPR.com

Jun 13, 2025

Jun 13, 2025

FDA approves Amneal’s prednisolone acetate eye drops, launch set for Q3 - Investing.com India

Jun 13, 2025

Jun 13, 2025

FDA approves Amneal's prednisolone acetate ophthalmic suspension - Eyes On Eyecare

Jun 13, 2025

Jun 12, 2025

Insider Sell: Gautam Patel Sells 56,426 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

Jun 12, 2025

Jun 12, 2025

Amneal Pharmaceuticals receives U.S. FDA approval for prednisolone acetate - TipRanks

Jun 12, 2025

Jun 12, 2025

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension - MarketScreener

Jun 12, 2025

Jun 12, 2025

Amneal Pharmaceuticals (AMRX) Gains FDA Approval for Eye Drug | AMRX Stock News - GuruFocus

Jun 12, 2025

Jun 12, 2025

FDA Green Lights Amneal's $201M Generic Eye Drug: Q3 2025 Launch Set for Pred Forte Alternative - Stock Titan

Jun 12, 2025

Jun 11, 2025

Amneal Recalls Oral Antibiotic Over Contamination Issue - Infectious Disease Advisor

Jun 11, 2025